First Summit of Barcelona Health Hub, global and international ecosystem for the health transformation
3rd October 2019 Sant Pau Art Nouveau Site
It will be an event for associate members and contributors of Barcelona Health Hub with an international dissemination.
Barcelona Health Hub Summit will be held on 3rd October 2019 in Sant Pau Art Nouveau Site, the biggest modernist centre in Europe.
Save the date… 3rd October 2019
It will include keynote presentations, panel discussions, startup showcases, business meetings and networking to foster synergies and interactions between startups, corporations and investors.
Get national and international visibility
Showcase your organization and share the work you are doing
Get access and network with 400+ innovative companies from Spain and abroad
Join international, top level startups and companies with innovative products and successful solutions
#BHHSummit19
Medical Director Global Healthcare practice and Head of Universal Healthcare at KPMG.
Niti Pall is medical Director for KPMG’s global healthcare practice .She leads the universal health coverage (UHC) team for the practice, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Centre for Universal Health Coverage.
Niti is a senior Doctor who has deep expertise in primary care models and health benefit management across the world. Niti helped to build up the largest chain of primary care clinics in the UK – the Modality Partnership – and held several senior commissioning roles in the English NHS. She established a chain of primary care clinics in India. She was Medical and Innovation Director of Emerging Markets for BUPA, where she helped to create an innovative model of micro-insurance in Bangladesh in partnership with Telenor. She established and supervised clinics in China, Saudi Arabia, Poland and Hong Kong and helped create health benefit management systems in Saudi Arabia,UK, India, Hong Kong, and Thailand.
In her current role with the global healthcare practice helped KPMG India secure the implementation of Modicare in 4 states delivering benefits to over 300 million people. She and the UHC team have helped KPMG in Indonesia, Vietnam, Philippines, Kazakhstan, Saudi Arabia and Sri Lanka win substantial work.
She holds a senior mobile health consultant role with AXA and is working with the emerging customer team to create smart new solutions around financial protection in healthcare in India, Indonesia, Thailand and Nigeria.
She is passionate about affordable healthcare and is working in many countries on smart digital health solutions with new distribution models. She is also Chair elect of the international Diabetes Federation Europe and works across Europe in Diabetes advocacy. She has helped develop numerous patient centred diabetes solution across the globe including prevention strategies for government.
Chief Innovation and Transformation Officer at Yale New Haven Health System
Peter G. Schulam, MD, PhD, has served since 2012 as the inaugural chair of the Department of Urology at Yale School of Medicine and chief of the Department of Urology at Yale New Haven Hospital. In addition, he served as interim director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital from September 2015 through December 2016.
Dr. Schulam is professor of both urology and surgery. He is also co-founder of Yale’s Center for Biomedical Innovation and Technology (CBIT) and the inaugural faculty director of the Tsai Center for Innovative Thinking at Yale (CITY). In June 2018, Dr. Schulam was also named chief innovation and transformation officer at Yale New Haven Health System.
Prior to joining Yale, Dr. Schulam was the Henry E. Singleton Professor of Urology at the Ronald Reagan Medical Center at University of California, Los Angeles where he served as vice chair of Urology, chief of the division of Endourology and minimally invasive surgery, and director of the surgical living kidney donor program. Dr. Schulam was a recipient of the Medical Scientist Training Program award and received his Medical Degree as well as his PhD in Immunology at Baylor College of Medicine in Houston. He completed his urology residency at The Johns Hopkins Hospital in Baltimore.
Vice President/ Chief Population Health Officer at Northeast Medical Group/ Yale New Haven Health System
Dr. DoRosario is Board Certified in Internal Medicine, Geriatric Medicine, and has over 30 years of experience as a primary care physician.
He was the founding member and Medical Director of PriMed, a large multispecialty physician group that excelled in Quality Incentive Programs, Care Coordination, and early adoption of technology. In 2014, Dr. DoRosario joined the Yale New Haven Health System and served as Chief Medical Officer for NEMG/Yale New Haven Health, a multispecialty ambulatory group of over 700 physicians.
Dr. DoRosario has held various leadership roles and served on advisory councils related to quality, performance improvement, patient experience, and population health. He has also held faculty appointments in Columbia University School of Medicine, Quinnipiac University School of Medicine, and Yale School of Medicine. He is the recipient of multiple awards for excellence in patient care and teaching.
Dr. DoRosario completed his undergraduate education at Strathmore College, Nairobi, Kenya, East Africa and graduated from the Universidad de Navarra, Facultad de Medicina, Pamplona, Spain. He completed his residency at St. Vincent’s Medical Center/Yale School of Medicine. He currently serves as Chief Population Health Officer at Northeast Medical Group/YNHHS.
Niti Pall is medical Director for KPMG’s global healthcare practice .She leads the universal health coverage (UHC) team for the practice, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Centre for Universal Health Coverage.
Niti Pall is medical Director for KPMG’s global healthcare practice .She leads the universal health coverage (UHC) team for the practice, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Centre for Universal Health Coverage.
What do you wish you had known before fundraising? Getting an investor on board is like a marriage, you are in for the long run. How do you choose the best partner? Successful entrepreneurs who closed multiple investment rounds, in a panel moderated by an early stage healthcare investor, share their (hard-) learned lessons about fundraising and tips on how to raise more money in Europe and beyond.
What do you wish you had known before fundraising? Getting an investor on board is like a marriage, you are in for the long run. How do you choose the best partner? Successful entrepreneurs who closed multiple investment rounds, in a panel moderated by an early stage healthcare investor, share their (hard-) learned lessons about fundraising and tips on how to raise more money in Europe and beyond
Bringing Patients & Healthcare Professionals Closer (Solutions that support patients and facilitate the communication with healthcare professionals)
Virtual Bodyworks is a company committed to improving lives by harnessing the power of scientifically-proven breakthrough technology. They specialise in immersive virtual reality focused on medical and psychological rehabilitation.
Made of Genes uses DNA analisis’ results to improve patients’health in a personalized way
Medify helps patients understand healthcare better, by breaking complex medical information into easy to understand videos.
Docline connects doctors and patients, through online video consultations and online treatments
Solutions for Healthcare Institutions
Solutions that can support healthcare institutions and healthcare professionals
Iomed combines electronic health records database with machine learning to get accurate results, improve research outcome and reduce the time to market by streamlining the clinical trials.
Relyens (Sham) is a european mutual insurance and risk management group for healthcare providers and local authorities
Bitac improves the quality of clinical information through the use of standards by providing tools specialized in clinical technology. Bitac is the platform which combines the best of both clinicians and data scientists.
Stacks is a company in the ICT sector specialized in the design of solutions oriented exclusively to the health sector.
More and more pharma companies are working with startups to help them improve the strength of their data and bring efficiencies with regard to time and costs. Our panelists will discuss the potential of new technologies for pharma companies in the era of Real World Evidence, the impact of regulation and what the collaboration pharma-startups looks like with its challenges and lessons learnt.
More and more pharma companies are working with startups to help them improve the strength of their data and bring efficiencies with regard to time and costs. Our panelists will discuss the potential of new technologies for pharma companies in the era of Real World Evidence, the impact of regulation and what the collaboration pharma-startups looks like with its challenges and lessons learnt.
What will it take to accelerate the collaboration between the insurance industry and startups to digitize their services? Why are so many insurance companies looking into healthcare? What does it mean for the end users? Health insurances and entrepreneurs will share their journey and lessons learnt and discuss the collaboration and best business models.
Licenciado en Medicina por la Universidad Autónoma de Barcelona y doctor en Administración
y Dirección de Empresas por la Universitat Politècnica de Catalunya. Graduado por la Stanford
Graduated School of Business. También es diplomado en Gestión Hospitalaria y en
Administración y Dirección de Empresas por ESADE, y en Economía de la Salud por la
Universidad de Barcelona.
CEO de DKV Seguros, Presidente de la Fundación Integralia DKV y Presidente de Marina Salud.
Desde 2017 también es Presidente de DAS España.
Previamente desarrolló su carrera profesional como director de diferentes hospitales.
Es miembro del Plenario de la Cámara de Comercio de Barcelona y es miembro de varias
fundaciones de índole social (Plant for the Planet, Ship2B, Oxfam Intermón, etc.).
Law degree University of Barcelona, Master in Finance Deusto Business School, Global executive CEO program at IESE – Wharton – CEIBS, Pade at ESE and IMD Executive Management.
CEO Barcelona Health & Community of Insurance. Expert on updating companies to the digital age.
Before, he was CEO Life and pensions at Zurich in Spain. Member of the leadership team at Zurich Insurance (Top 100) and Executive Committee of Global Life. Board member of several Companies at Zurtich Group in Spain and Portugal.
Previously CEO at Deutsche Bank Insurance Group and Managing Director at Vitalicio for Iberia – Generali Group.
Since september 2019, Elena is member of the WHO Roster of Experts for Digital Health
What will it take to accelerate the collaboration between the insurance industry and startups to digitize their services? Why are so many insurance companies looking into healthcare? What does it mean for the end users? Health insurances and entrepreneurs will share their journey and lessons learnt and discuss the collaboration and best business models.
Licenciado en Medicina por la Universidad Autónoma de Barcelona y doctor en Administración
y Dirección de Empresas por la Universitat Politècnica de Catalunya. Graduado por la Stanford
Graduated School of Business. También es diplomado en Gestión Hospitalaria y en
Administración y Dirección de Empresas por ESADE, y en Economía de la Salud por la
Universidad de Barcelona.
CEO de DKV Seguros, Presidente de la Fundación Integralia DKV y Presidente de Marina Salud.
Desde 2017 también es Presidente de DAS España.
Previamente desarrolló su carrera profesional como director de diferentes hospitales.
Es miembro del Plenario de la Cámara de Comercio de Barcelona y es miembro de varias
fundaciones de índole social (Plant for the Planet, Ship2B, Oxfam Intermón, etc.).
Law degree University of Barcelona, Master in Finance Deusto Business School, Global executive CEO program at IESE – Wharton – CEIBS, Pade at ESE and IMD Executive Management.
CEO Barcelona Health & Community of Insurance. Expert on updating companies to the digital age.
Before, he was CEO Life and pensions at Zurich in Spain. Member of the leadership team at Zurich Insurance (Top 100) and Executive Committee of Global Life. Board member of several Companies at Zurtich Group in Spain and Portugal.
Previously CEO at Deutsche Bank Insurance Group and Managing Director at Vitalicio for Iberia – Generali Group.
Since september 2019, Elena is member of the WHO Roster of Experts for Digital Health
Tools to Empower Patients (Solutions that empower patients to take better control of their health)
Medlia brings health in your hands: with Medlia app, you can book an appointment, do a video consultation and get an e-prescription on your mobile.
With leadquarters in Lagos, Hadiel is an emerging Insurtech startup which is bringing all the players from the Industry on a single platform keeping the end user at the centre of its strategy.
Rehand is revolutionising the rehabilitation of hand through gamification and improving functions of different parts of the hand.
Mediktor is the most accurate AI based medical assistant for prediagnosis, triage and decision-making support.
We present as an exclusive premiere, the Cough Analyzer: A brand-new AI based medical assistant developed by Mediktor in collaboration with Sanofi.
Hosted by Toni Sureda, Project Manager of Mediktor.
Dr. DoRosario is Board Certified in Internal Medicine, Geriatric Medicine, and has over 30 years of experience as a primary care physician.
He was the founding member and Medical Director of PriMed, a large multispecialty physician group that excelled in Quality Incentive Programs, Care Coordination, and early adoption of technology. In 2014, Dr. DoRosario joined the Yale New Haven Health System and served as Chief Medical Officer for NEMG/Yale New Haven Health, a multispecialty ambulatory group of over 700 physicians.
Peter G. Schulam, MD, PhD, has served since 2012 as the inaugural chair of the Department of Urology at Yale School of Medicine and chief of the Department of Urology at Yale New Haven Hospital. In addition, he served as interim director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital from September 2015 through December 2016.
Dr. DoRosario is Board Certified in Internal Medicine, Geriatric Medicine, and has over 30 years of experience as a primary care physician.
He was the founding member and Medical Director of PriMed, a large multispecialty physician group that excelled in Quality Incentive Programs, Care Coordination, and early adoption of technology. In 2014, Dr. DoRosario joined the Yale New Haven Health System and served as Chief Medical Officer for NEMG/Yale New Haven Health, a multispecialty ambulatory group of over 700 physicians.
Peter G. Schulam, MD, PhD, has served since 2012 as the inaugural chair of the Department of Urology at Yale School of Medicine and chief of the Department of Urology at Yale New Haven Hospital. In addition, he served as interim director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital from September 2015 through December 2016.
Startups are developing solutions that can improve processes and support healthcare professionals in being more efficient. But how can startups work successfully with hospitals and integrate with their legacy system? Clinical validation is necessary for startups to push their solution to the market but they often end up in pilot cycles. How can they exit those pilots and start establishing a commercial relationship with healthcare providers? Our expert panelists will deep down on all those questions.
Professor Julio is a general and colorectal surgeon and currently serves as Chief Medical and
Innovation Officer at Hospital Clinico San Carlos, Madrid and Professor of Surgery at
Universidad Complutense de Madrid.
As a corresponding member, he is the current chief networking officer of the Royal Academy
of Medicine of Spain.
In 2018, he became President of the Spanish Society for Surgical Research. He has been a
member of the BJSS Council and has been Secretary of the BJS Society since 2018. He served
on the International Relations and Giving Back committees of the Society for Surgery of the
Alimentary Tract, USA until May. Professor Julio Mayol is the Guest Editor of the Summer Issue
of JASGBI.
In 2018 he launched #SoMe4Surgery, a Twitter community devoted to connecting all those
interested in advancing surgery (surgeons, researchers, healthcare professionals, and patients)
through a global conversation.
Passionate about Social Networks and communication, he has 27,000 followers on his Twitter
profile, writes a Blog and in June 2016 he published his first book “La guardia del Dr. Klint”.
Startups are developing solutions that can improve processes and support healthcare professionals in being more efficient. But how can startups work successfully with hospitals and integrate with their legacy system? Clinical validation is necessary for startups to push their solution to the market but they often end up in pilot cycles. How can they exit those pilots and start establishing a commercial relationship with healthcare providers? Our expert panelists will deep down on all those questions.
Professor Julio is a general and colorectal surgeon and currently serves as Chief Medical and
Innovation Officer at Hospital Clinico San Carlos, Madrid and Professor of Surgery at
Universidad Complutense de Madrid.
As a corresponding member, he is the current chief networking officer of the Royal Academy
of Medicine of Spain.
In 2018, he became President of the Spanish Society for Surgical Research. He has been a
member of the BJSS Council and has been Secretary of the BJS Society since 2018. He served
on the International Relations and Giving Back committees of the Society for Surgery of the
Alimentary Tract, USA until May. Professor Julio Mayol is the Guest Editor of the Summer Issue
of JASGBI.
In 2018 he launched #SoMe4Surgery, a Twitter community devoted to connecting all those
interested in advancing surgery (surgeons, researchers, healthcare professionals, and patients)
through a global conversation.
Passionate about Social Networks and communication, he has 27,000 followers on his Twitter
profile, writes a Blog and in June 2016 he published his first book “La guardia del Dr. Klint”.
Digital Health Solutions: What’s Next? (Solutions that go a step further, using exponential technologies that will revolutionize the future of healthcare)
The API marketplace for Health. Nubentos introduces the API Economy in healthcare, so that the software used by the healthcare professional integrates, quickly and cost effectively, all the progress that Connected Health is bringing and will bring in the coming decades.
Neurogress team develops a decentralized platform of neural control systems, based on the AI driven software and user-driven algorithm training. This goal can be achieved using a complex approach with a decentralised ecosystem.
Mental ID is the human interface for deep machine learning and AI. Their proprietary Deep Identity Clarifying Process™ predicts and solves human conditioning-related risks and trust issues.
Healthcare Anywhere Anytime (Solutions that go where the patient is)
E-Health platform for international trips to tropical destinations. TripDoctor offers a new way of travelling with your doctor, safe and sound, to avoid disease complications and unnecessary hospital consultations at destination.
UniversalDoctor is a social enterprise developing technology solutions for global health. They are breaking the language barriers through customized multi lingual medical records.
A global insurer whose strategy focuses on providing the right general insurance and life insurance solutions for its individual, small business, medium-sized business and corporates customers.
UrbanFisio is the new way to experience and book a personalized and quality home physiotherapy service
What does it take to go from 4 employees to 200? How can you scale your company successfully? Successful scaleup companies and experts will share what they learned along the way and the keys to be where they are today. They will also discuss the challenges and opportunities of scaling up in an ecosystem like Barcelona or Spain.
Lukas joined dacadoo in 2015 as Sales Director Europe. In January 2019 he expanded his regional responsibility to EMEA.
Following his Master Degree in Sport Technology and Administration at the EPFL in Lausanne, Lukas moved to Singapore where he joined World Sport Group Pte Ltd (now a part of the Lagardère Group) – Asia’s leading Sport Marketing and Media Agency. From 2008 – 2013 Lukas worked in various sales, marketing & business development roles at World Sport Group, operating mainly in South East Asia, Australia and Uzbekistan. After his return to Europe, Lukas joined a high precision wearable technology company mainly used in Formula 1 before he joined dacadoo.
Mr. Miguel Valls is an established serial entrepreneur and investor in Spain and
Silicon Valley and a former investment banker with several successful investments
in life science and tech companies.
Mr. Valls is Founding General Partner of Alta life sciences, a multi stage life sciences
investment firm based in Silicon valley and Barcelona.
Mr. Valls is co-Founder and Chairman of Dadata Capital and has been the co-
founder, investor and advisor to biotech companies like Genotesta, Clear Labs, Base
Health and tech companies like Spirit Films and Nektria and vLex.
Miguel is also the co-founder and co-chair of the San Francisco-Barcelona Sister
City Committee and Technology Advisor to the Spain Chambers of Commerce.
He created the International Technology Forum in 2007, the first program to bring
Silicon Valley investors to Spain.
Mr. Valls also has extensive experience in Derivatives (Siaga A.V.B) and Money
Management (Barclays Private Banking, BNP-Paribas Private Banking).
Mr. Valls holds a Bachelor in Law from University of Barcelona, an Executive
Education Degree from University of California, Berkeley and a Blockchain strategy
program from Said Business school, University of Oxford. He also has the following
certifications: European Financial Advisor (EFPA), Derivatives Broker-Dealer (MEFF)
European Financial Analyst (EFA) and Technical and Chartist Analyst (IEF).
What does it take to go from 4 employees to 200? How can you scale your company successfully? Successful scaleup companies and experts will share what they learned along the way and the keys to be where they are today. They will also discuss the challenges and opportunities of scaling up in an ecosystem like Barcelona or Spain.
Lukas joined dacadoo in 2015 as Sales Director Europe. In January 2019 he expanded his regional responsibility to EMEA.
Following his Master Degree in Sport Technology and Administration at the EPFL in Lausanne, Lukas moved to Singapore where he joined World Sport Group Pte Ltd (now a part of the Lagardère Group) – Asia’s leading Sport Marketing and Media Agency. From 2008 – 2013 Lukas worked in various sales, marketing & business development roles at World Sport Group, operating mainly in South East Asia, Australia and Uzbekistan. After his return to Europe, Lukas joined a high precision wearable technology company mainly used in Formula 1 before he joined dacadoo.
Mr. Miguel Valls is an established serial entrepreneur and investor in Spain and
Silicon Valley and a former investment banker with several successful investments
in life science and tech companies.
Mr. Valls is Founding General Partner of Alta life sciences, a multi stage life sciences
investment firm based in Silicon valley and Barcelona.
Mr. Valls is co-Founder and Chairman of Dadata Capital and has been the co-
founder, investor and advisor to biotech companies like Genotesta, Clear Labs, Base
Health and tech companies like Spirit Films and Nektria and vLex.
Miguel is also the co-founder and co-chair of the San Francisco-Barcelona Sister
City Committee and Technology Advisor to the Spain Chambers of Commerce.
He created the International Technology Forum in 2007, the first program to bring
Silicon Valley investors to Spain.
Mr. Valls also has extensive experience in Derivatives (Siaga A.V.B) and Money
Management (Barclays Private Banking, BNP-Paribas Private Banking).
Mr. Valls holds a Bachelor in Law from University of Barcelona, an Executive
Education Degree from University of California, Berkeley and a Blockchain strategy
program from Said Business school, University of Oxford. He also has the following
certifications: European Financial Advisor (EFPA), Derivatives Broker-Dealer (MEFF)
European Financial Analyst (EFA) and Technical and Chartist Analyst (IEF).
Niti Pall is medical Director for KPMG’s global healthcare practice .She leads the universal health coverage (UHC) team for the practice, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Centre for Universal Health Coverage.
Niti Pall is medical Director for KPMG’s global healthcare practice .She leads the universal health coverage (UHC) team for the practice, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Centre for Universal Health Coverage.
What do you wish you had known before fundraising? Getting an investor on board is like a marriage, you are in for the long run. How do you choose the best partner? Successful entrepreneurs who closed multiple investment rounds, in a panel moderated by an early stage healthcare investor, share their (hard-) learned lessons about fundraising and tips on how to raise more money in Europe and beyond.
What do you wish you had known before fundraising? Getting an investor on board is like a marriage, you are in for the long run. How do you choose the best partner? Successful entrepreneurs who closed multiple investment rounds, in a panel moderated by an early stage healthcare investor, share their (hard-) learned lessons about fundraising and tips on how to raise more money in Europe and beyond
Bringing Patients & Healthcare Professionals Closer (Solutions that support patients and facilitate the communication with healthcare professionals)
Virtual Bodyworks is a company committed to improving lives by harnessing the power of scientifically-proven breakthrough technology. They specialise in immersive virtual reality focused on medical and psychological rehabilitation.
Made of Genes uses DNA analisis’ results to improve patients’health in a personalized way
Medify helps patients understand healthcare better, by breaking complex medical information into easy to understand videos.
Docline connects doctors and patients, through online video consultations and online treatments
Solutions for Healthcare Institutions
Solutions that can support healthcare institutions and healthcare professionals
Iomed combines electronic health records database with machine learning to get accurate results, improve research outcome and reduce the time to market by streamlining the clinical trials.
Relyens (Sham) is a european mutual insurance and risk management group for healthcare providers and local authorities
Bitac improves the quality of clinical information through the use of standards by providing tools specialized in clinical technology. Bitac is the platform which combines the best of both clinicians and data scientists.
Stacks is a company in the ICT sector specialized in the design of solutions oriented exclusively to the health sector.
More and more pharma companies are working with startups to help them improve the strength of their data and bring efficiencies with regard to time and costs. Our panelists will discuss the potential of new technologies for pharma companies in the era of Real World Evidence, the impact of regulation and what the collaboration pharma-startups looks like with its challenges and lessons learnt.
More and more pharma companies are working with startups to help them improve the strength of their data and bring efficiencies with regard to time and costs. Our panelists will discuss the potential of new technologies for pharma companies in the era of Real World Evidence, the impact of regulation and what the collaboration pharma-startups looks like with its challenges and lessons learnt.
What will it take to accelerate the collaboration between the insurance industry and startups to digitize their services? Why are so many insurance companies looking into healthcare? What does it mean for the end users? Health insurances and entrepreneurs will share their journey and lessons learnt and discuss the collaboration and best business models.
Licenciado en Medicina por la Universidad Autónoma de Barcelona y doctor en Administración
y Dirección de Empresas por la Universitat Politècnica de Catalunya. Graduado por la Stanford
Graduated School of Business. También es diplomado en Gestión Hospitalaria y en
Administración y Dirección de Empresas por ESADE, y en Economía de la Salud por la
Universidad de Barcelona.
CEO de DKV Seguros, Presidente de la Fundación Integralia DKV y Presidente de Marina Salud.
Desde 2017 también es Presidente de DAS España.
Previamente desarrolló su carrera profesional como director de diferentes hospitales.
Es miembro del Plenario de la Cámara de Comercio de Barcelona y es miembro de varias
fundaciones de índole social (Plant for the Planet, Ship2B, Oxfam Intermón, etc.).
Law degree University of Barcelona, Master in Finance Deusto Business School, Global executive CEO program at IESE – Wharton – CEIBS, Pade at ESE and IMD Executive Management.
CEO Barcelona Health & Community of Insurance. Expert on updating companies to the digital age.
Before, he was CEO Life and pensions at Zurich in Spain. Member of the leadership team at Zurich Insurance (Top 100) and Executive Committee of Global Life. Board member of several Companies at Zurtich Group in Spain and Portugal.
Previously CEO at Deutsche Bank Insurance Group and Managing Director at Vitalicio for Iberia – Generali Group.
Since september 2019, Elena is member of the WHO Roster of Experts for Digital Health
What will it take to accelerate the collaboration between the insurance industry and startups to digitize their services? Why are so many insurance companies looking into healthcare? What does it mean for the end users? Health insurances and entrepreneurs will share their journey and lessons learnt and discuss the collaboration and best business models.
Licenciado en Medicina por la Universidad Autónoma de Barcelona y doctor en Administración
y Dirección de Empresas por la Universitat Politècnica de Catalunya. Graduado por la Stanford
Graduated School of Business. También es diplomado en Gestión Hospitalaria y en
Administración y Dirección de Empresas por ESADE, y en Economía de la Salud por la
Universidad de Barcelona.
CEO de DKV Seguros, Presidente de la Fundación Integralia DKV y Presidente de Marina Salud.
Desde 2017 también es Presidente de DAS España.
Previamente desarrolló su carrera profesional como director de diferentes hospitales.
Es miembro del Plenario de la Cámara de Comercio de Barcelona y es miembro de varias
fundaciones de índole social (Plant for the Planet, Ship2B, Oxfam Intermón, etc.).
Law degree University of Barcelona, Master in Finance Deusto Business School, Global executive CEO program at IESE – Wharton – CEIBS, Pade at ESE and IMD Executive Management.
CEO Barcelona Health & Community of Insurance. Expert on updating companies to the digital age.
Before, he was CEO Life and pensions at Zurich in Spain. Member of the leadership team at Zurich Insurance (Top 100) and Executive Committee of Global Life. Board member of several Companies at Zurtich Group in Spain and Portugal.
Previously CEO at Deutsche Bank Insurance Group and Managing Director at Vitalicio for Iberia – Generali Group.
Since september 2019, Elena is member of the WHO Roster of Experts for Digital Health
Tools to Empower Patients (Solutions that empower patients to take better control of their health)
Medlia brings health in your hands: with Medlia app, you can book an appointment, do a video consultation and get an e-prescription on your mobile.
With leadquarters in Lagos, Hadiel is an emerging Insurtech startup which is bringing all the players from the Industry on a single platform keeping the end user at the centre of its strategy.
Rehand is revolutionising the rehabilitation of hand through gamification and improving functions of different parts of the hand.
Mediktor is the most accurate AI based medical assistant for prediagnosis, triage and decision-making support.
We present as an exclusive premiere, the Cough Analyzer: A brand-new AI based medical assistant developed by Mediktor in collaboration with Sanofi.
Hosted by Toni Sureda, Project Manager of Mediktor.
Dr. DoRosario is Board Certified in Internal Medicine, Geriatric Medicine, and has over 30 years of experience as a primary care physician.
He was the founding member and Medical Director of PriMed, a large multispecialty physician group that excelled in Quality Incentive Programs, Care Coordination, and early adoption of technology. In 2014, Dr. DoRosario joined the Yale New Haven Health System and served as Chief Medical Officer for NEMG/Yale New Haven Health, a multispecialty ambulatory group of over 700 physicians.
Peter G. Schulam, MD, PhD, has served since 2012 as the inaugural chair of the Department of Urology at Yale School of Medicine and chief of the Department of Urology at Yale New Haven Hospital. In addition, he served as interim director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital from September 2015 through December 2016.
Dr. DoRosario is Board Certified in Internal Medicine, Geriatric Medicine, and has over 30 years of experience as a primary care physician.
He was the founding member and Medical Director of PriMed, a large multispecialty physician group that excelled in Quality Incentive Programs, Care Coordination, and early adoption of technology. In 2014, Dr. DoRosario joined the Yale New Haven Health System and served as Chief Medical Officer for NEMG/Yale New Haven Health, a multispecialty ambulatory group of over 700 physicians.
Peter G. Schulam, MD, PhD, has served since 2012 as the inaugural chair of the Department of Urology at Yale School of Medicine and chief of the Department of Urology at Yale New Haven Hospital. In addition, he served as interim director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital from September 2015 through December 2016.
Startups are developing solutions that can improve processes and support healthcare professionals in being more efficient. But how can startups work successfully with hospitals and integrate with their legacy system? Clinical validation is necessary for startups to push their solution to the market but they often end up in pilot cycles. How can they exit those pilots and start establishing a commercial relationship with healthcare providers? Our expert panelists will deep down on all those questions.
Professor Julio is a general and colorectal surgeon and currently serves as Chief Medical and
Innovation Officer at Hospital Clinico San Carlos, Madrid and Professor of Surgery at
Universidad Complutense de Madrid.
As a corresponding member, he is the current chief networking officer of the Royal Academy
of Medicine of Spain.
In 2018, he became President of the Spanish Society for Surgical Research. He has been a
member of the BJSS Council and has been Secretary of the BJS Society since 2018. He served
on the International Relations and Giving Back committees of the Society for Surgery of the
Alimentary Tract, USA until May. Professor Julio Mayol is the Guest Editor of the Summer Issue
of JASGBI.
In 2018 he launched #SoMe4Surgery, a Twitter community devoted to connecting all those
interested in advancing surgery (surgeons, researchers, healthcare professionals, and patients)
through a global conversation.
Passionate about Social Networks and communication, he has 27,000 followers on his Twitter
profile, writes a Blog and in June 2016 he published his first book “La guardia del Dr. Klint”.
Startups are developing solutions that can improve processes and support healthcare professionals in being more efficient. But how can startups work successfully with hospitals and integrate with their legacy system? Clinical validation is necessary for startups to push their solution to the market but they often end up in pilot cycles. How can they exit those pilots and start establishing a commercial relationship with healthcare providers? Our expert panelists will deep down on all those questions.
Professor Julio is a general and colorectal surgeon and currently serves as Chief Medical and
Innovation Officer at Hospital Clinico San Carlos, Madrid and Professor of Surgery at
Universidad Complutense de Madrid.
As a corresponding member, he is the current chief networking officer of the Royal Academy
of Medicine of Spain.
In 2018, he became President of the Spanish Society for Surgical Research. He has been a
member of the BJSS Council and has been Secretary of the BJS Society since 2018. He served
on the International Relations and Giving Back committees of the Society for Surgery of the
Alimentary Tract, USA until May. Professor Julio Mayol is the Guest Editor of the Summer Issue
of JASGBI.
In 2018 he launched #SoMe4Surgery, a Twitter community devoted to connecting all those
interested in advancing surgery (surgeons, researchers, healthcare professionals, and patients)
through a global conversation.
Passionate about Social Networks and communication, he has 27,000 followers on his Twitter
profile, writes a Blog and in June 2016 he published his first book “La guardia del Dr. Klint”.
Digital Health Solutions: What’s Next? (Solutions that go a step further, using exponential technologies that will revolutionize the future of healthcare)
The API marketplace for Health. Nubentos introduces the API Economy in healthcare, so that the software used by the healthcare professional integrates, quickly and cost effectively, all the progress that Connected Health is bringing and will bring in the coming decades.
Neurogress team develops a decentralized platform of neural control systems, based on the AI driven software and user-driven algorithm training. This goal can be achieved using a complex approach with a decentralised ecosystem.
Mental ID is the human interface for deep machine learning and AI. Their proprietary Deep Identity Clarifying Process™ predicts and solves human conditioning-related risks and trust issues.
Healthcare Anywhere Anytime (Solutions that go where the patient is)
E-Health platform for international trips to tropical destinations. TripDoctor offers a new way of travelling with your doctor, safe and sound, to avoid disease complications and unnecessary hospital consultations at destination.
UniversalDoctor is a social enterprise developing technology solutions for global health. They are breaking the language barriers through customized multi lingual medical records.
A global insurer whose strategy focuses on providing the right general insurance and life insurance solutions for its individual, small business, medium-sized business and corporates customers.
UrbanFisio is the new way to experience and book a personalized and quality home physiotherapy service
What does it take to go from 4 employees to 200? How can you scale your company successfully? Successful scaleup companies and experts will share what they learned along the way and the keys to be where they are today. They will also discuss the challenges and opportunities of scaling up in an ecosystem like Barcelona or Spain.
Lukas joined dacadoo in 2015 as Sales Director Europe. In January 2019 he expanded his regional responsibility to EMEA.
Following his Master Degree in Sport Technology and Administration at the EPFL in Lausanne, Lukas moved to Singapore where he joined World Sport Group Pte Ltd (now a part of the Lagardère Group) – Asia’s leading Sport Marketing and Media Agency. From 2008 – 2013 Lukas worked in various sales, marketing & business development roles at World Sport Group, operating mainly in South East Asia, Australia and Uzbekistan. After his return to Europe, Lukas joined a high precision wearable technology company mainly used in Formula 1 before he joined dacadoo.
Mr. Miguel Valls is an established serial entrepreneur and investor in Spain and
Silicon Valley and a former investment banker with several successful investments
in life science and tech companies.
Mr. Valls is Founding General Partner of Alta life sciences, a multi stage life sciences
investment firm based in Silicon valley and Barcelona.
Mr. Valls is co-Founder and Chairman of Dadata Capital and has been the co-
founder, investor and advisor to biotech companies like Genotesta, Clear Labs, Base
Health and tech companies like Spirit Films and Nektria and vLex.
Miguel is also the co-founder and co-chair of the San Francisco-Barcelona Sister
City Committee and Technology Advisor to the Spain Chambers of Commerce.
He created the International Technology Forum in 2007, the first program to bring
Silicon Valley investors to Spain.
Mr. Valls also has extensive experience in Derivatives (Siaga A.V.B) and Money
Management (Barclays Private Banking, BNP-Paribas Private Banking).
Mr. Valls holds a Bachelor in Law from University of Barcelona, an Executive
Education Degree from University of California, Berkeley and a Blockchain strategy
program from Said Business school, University of Oxford. He also has the following
certifications: European Financial Advisor (EFPA), Derivatives Broker-Dealer (MEFF)
European Financial Analyst (EFA) and Technical and Chartist Analyst (IEF).
What does it take to go from 4 employees to 200? How can you scale your company successfully? Successful scaleup companies and experts will share what they learned along the way and the keys to be where they are today. They will also discuss the challenges and opportunities of scaling up in an ecosystem like Barcelona or Spain.
Lukas joined dacadoo in 2015 as Sales Director Europe. In January 2019 he expanded his regional responsibility to EMEA.
Following his Master Degree in Sport Technology and Administration at the EPFL in Lausanne, Lukas moved to Singapore where he joined World Sport Group Pte Ltd (now a part of the Lagardère Group) – Asia’s leading Sport Marketing and Media Agency. From 2008 – 2013 Lukas worked in various sales, marketing & business development roles at World Sport Group, operating mainly in South East Asia, Australia and Uzbekistan. After his return to Europe, Lukas joined a high precision wearable technology company mainly used in Formula 1 before he joined dacadoo.
Mr. Miguel Valls is an established serial entrepreneur and investor in Spain and
Silicon Valley and a former investment banker with several successful investments
in life science and tech companies.
Mr. Valls is Founding General Partner of Alta life sciences, a multi stage life sciences
investment firm based in Silicon valley and Barcelona.
Mr. Valls is co-Founder and Chairman of Dadata Capital and has been the co-
founder, investor and advisor to biotech companies like Genotesta, Clear Labs, Base
Health and tech companies like Spirit Films and Nektria and vLex.
Miguel is also the co-founder and co-chair of the San Francisco-Barcelona Sister
City Committee and Technology Advisor to the Spain Chambers of Commerce.
He created the International Technology Forum in 2007, the first program to bring
Silicon Valley investors to Spain.
Mr. Valls also has extensive experience in Derivatives (Siaga A.V.B) and Money
Management (Barclays Private Banking, BNP-Paribas Private Banking).
Mr. Valls holds a Bachelor in Law from University of Barcelona, an Executive
Education Degree from University of California, Berkeley and a Blockchain strategy
program from Said Business school, University of Oxford. He also has the following
certifications: European Financial Advisor (EFPA), Derivatives Broker-Dealer (MEFF)
European Financial Analyst (EFA) and Technical and Chartist Analyst (IEF).
10:45h a 11:15h Tax benefits for Investors and startup vehicles
Guadalupe Diaz-Súnico Aboitiz/ Tax Partner
12:15h a 12:45h Quiron Salud
Sr. Albert Martínez
13:15h a 13:45h How to get funding for your startup
Rafael Vallet Vila/ Corporate Partner
Miguel Lobón García/ Corporate Associate
15:00h a 15:45 Financiación Pública en el sector Health
F Iniciativas. Sr. Iban Morillas
16:00h a 16:30h How to get funding for your startup
Rafael Vallet Vila/ Corporate Partner
Miguel Lobón García/ Corporate Associate
17:00h a 17:30h Tax benefits for Investors and startup vehicles
Guadalupe Diaz-Súnico Aboitiz/ Tax Partner
Read more about the Challenges here https://ferrer4future.com/
From 2:00 pm to 3:15 pm One-to-one meetings (10 min slots)
Book a slot with Ferrer team here: https://forms.gle/oxanYNE6YgJKCjFg7 On the day of the event, there will be a log in system in the room to choose the exact time of the private meeting.
Throughout the day the room will be open to meet Ferrer’s team and have informal conversations.
From 11.15 am to 11.45 am & from 2.30 pm to 3.00 pm: Innovation @Bayer: Innovation processes& G4A program for startups
Do you know how Bayer faces the innovation process? Do you want to know more about the G4A program? We are looking forward to connecting with you!
Reference links:
Open Innovation @Bayer – https://innovate.bayer.com/
G4A program – https://www.g4a.health/
From 3.30 pm to 5.30 pm: Face-2-Face meetings (15’ slots) with startups
We would like to learn more about your idea and how you arrived where you are… we want to learn from you. We will reach out to startups to set up appointments but, if you are interested in meeting with us, feel free to send an email to anabel.leon@bayer.com.
Bayer meeting room will be open during the morning to anyone interested in meeting us: we are waiting for you!